doi: 10.1056/NEJMp1106984.
Epub 2011 Jun 27.
Changing end points in breast-cancer drug approval--the Avastin story
Affiliations
- PMID: 21707384
- DOI: 10.1056/NEJMp1106984
Item in Clipboard
Changing end points in breast-cancer drug approval--the Avastin story
N Engl J Med.
.
No abstract available
Comment in
-
The avastin story.N Engl J Med. 2011 Oct 13;365(15):1454-5. doi: 10.1056/NEJMc1109550. N Engl J Med. 2011. PMID: 21995408 No abstract available.
Similar articles
-
Avastin hearing leads to more uncertainty over drug's future.J Natl Cancer Inst. 2011 Aug 3;103(15):1148-50. doi: 10.1093/jnci/djr293. Epub 2011 Jul 18. J Natl Cancer Inst. 2011. PMID: 21768534 No abstract available.
-
Reputation and precedent in the bevacizumab decision.N Engl J Med. 2011 Jul 14;365(2):e3. doi: 10.1056/NEJMp1107201. Epub 2011 Jun 27. N Engl J Med. 2011. PMID: 21707383 No abstract available.
-
The avastin story.N Engl J Med. 2011 Oct 13;365(15):1454-5. doi: 10.1056/NEJMc1109550. N Engl J Med. 2011. PMID: 21995408 No abstract available.
-
Position paper: the need for head-to-head studies comparing Avastin versus Lucentis.Surv Ophthalmol. 2009 Nov-Dec;54(6):705-7. doi: 10.1016/j.survophthal.2009.08.002. Surv Ophthalmol. 2009. PMID: 19818262 Review. No abstract available.
-
Making genuine progress against metastatic breast cancer.J Clin Oncol. 2012 Oct 1;30(28):3448-51. doi: 10.1200/JCO.2012.43.6931. Epub 2012 Aug 27. J Clin Oncol. 2012. PMID: 22927527 Review. No abstract available.
Cited by
-
Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance).J Clin Oncol. 2016 Aug 1;34(22):2602-9. doi: 10.1200/JCO.2015.66.1595. Epub 2016 May 2. J Clin Oncol. 2016. PMID: 27138575 Free PMC article. Clinical Trial.
-
Role of randomized phase III trials in an era of effective targeted therapies.Nat Rev Clin Oncol. 2011 Dec 6;9(4):208-14. doi: 10.1038/nrclinonc.2011.190. Nat Rev Clin Oncol. 2011. PMID: 22143142 Review.
-
Clinical advances in the development of novel VEGFR2 inhibitors.Ann Transl Med. 2014 Dec;2(12):123. doi: 10.3978/j.issn.2305-5839.2014.08.14. Ann Transl Med. 2014. PMID: 25568876 Free PMC article. Review.
-
Incorporating biomarkers into clinical trial designs: points to consider.Nat Biotechnol. 2012 Jul 10;30(7):596-9. doi: 10.1038/nbt.2296. Nat Biotechnol. 2012. PMID: 22781677 No abstract available.
-
Perceived value drives use of routine asymptomatic surveillance PET/CT by physicians who treat head and neck cancer.Head Neck. 2020 May;42(5):974-987. doi: 10.1002/hed.26071. Epub 2020 Jan 10. Head Neck. 2020. PMID: 31919944 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
